Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05260047 · ClinicalTrials.gov registry record · NA

Culturally Responsive Community Driven Substance Use Recovery for Black and Latinx Population

A NA study of Opioid Use and Substance Use, sponsored by Yale University.

Recruiting
Registry status
NA
Development phase
525
Enrollment target
8
Study locations

NCT05260047 is a NA study of Opioid Use and Substance Use that is actively recruiting participants, run by Yale University. The registered enrollment target is 525 participants, below the 148,255-participant average among 105 other Opioid Use trials with a reported enrollment target (100% lower). The trial reports 8 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05260047, a NA study of Opioid Use and Substance Use, is actively recruiting participants, sponsored by Yale University.

RECRUITING
Registry status
NA
Development phase
525 participants
Enrollment target
8
Study locations

Study Summary

The main goal of this current study is to develop and optimize methods for increasing access to, uptake of, and engagement in MAT (Medication Assisted Treatment) among communities of color.

Conditions Studied

Opioid Use Substance Use Mental Health Issue Medication Assisted Treatment

Interventions

  • BEHAVIORAL IMANI
  • BEHAVIORAL Telehealth MAT
  • BEHAVIORAL Traditional MAT plus Referral and Linkage

Study Locations (8)

Connecticut

  • Mount Aery Baptist Church - Bridgeport
  • Principe of Peace Church - Bridgeport
  • Blackwell Memorial AME Church - Hartford
  • Iglesia Nuevo Comienzo - Hartford
  • Spottswood AME - New Britain
  • Varick Memorial AME Church - New Haven
  • Yale Program for Recovery and Community Health - New Haven
  • Casa de Oracion y Adoracion - New Haven

Trial Details

FieldValue
Enrollment Target 525 participants
Start Date 2022-07-20
Est. Completion 2026-10-01
Phase NA

Sponsor

Yale University

1,492 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05260047

The ClinicalTrials.gov registry entry for NCT05260047 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 525 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 148,255-participant average among 105 other Opioid Use trials with a reported enrollment target (100% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Opioid Use appearing as the primary indexed condition, and to 3 interventions - of which IMANI is the first listed.

NCT05260047 reports 8 study locations spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT05260047 about?

NCT05260047 is a clinical study titled "Culturally Responsive Community Driven Substance Use Recovery for Black and Latinx Population". The main goal of this current study is to develop and optimize methods for increasing access to, uptake of, and engagement in MAT (Medication Assisted Treatment) among communities of color.

What is the current status of trial NCT05260047?

This trial is currently recruiting. It is a NA study. The enrollment target is 525 participants. The study started on 2022-07-20. Estimated completion is 2026-10-01.

What conditions does trial NCT05260047 study?

This clinical trial studies the following conditions: Opioid Use, Substance Use, Mental Health Issue, Medication Assisted Treatment.

What interventions are being tested in trial NCT05260047?

The interventions under investigation include: IMANI (BEHAVIORAL), Telehealth MAT (BEHAVIORAL), Traditional MAT plus Referral and Linkage (BEHAVIORAL).

Who is sponsoring clinical trial NCT05260047?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05260047 being conducted?

This trial has 8 study locations across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Opioid Use

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Opioid Use

All registered trials for this condition

Substance Use

All registered trials for this condition

Connecticut

All trials with a study site in Connecticut

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.